These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
525 related articles for article (PubMed ID: 24920289)
1. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors. Partelli S; Maurizi A; Tamburrino D; Baldoni A; Polenta V; Crippa S; Falconi M Eur J Endocrinol; 2014 Oct; 171(4):R153-62. PubMed ID: 24920289 [TBL] [Abstract][Full Text] [Related]
2. Surgical management of neuroendocrine tumors. Tamburrino D; Spoletini G; Partelli S; Muffatti F; Adamenko O; Crippa S; Falconi M Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):93-102. PubMed ID: 26971846 [TBL] [Abstract][Full Text] [Related]
3. Surgery for GEP-NETs. Knigge U; Hansen CP Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):819-31. PubMed ID: 23582921 [TBL] [Abstract][Full Text] [Related]
4. Surgery for gastroenteropancreatic neuroendocrine tumors (GEPNETS). Boudreaux JP Endocrinol Metab Clin North Am; 2011 Mar; 40(1):163-71, ix. PubMed ID: 21349417 [TBL] [Abstract][Full Text] [Related]
5. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target. Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545 [TBL] [Abstract][Full Text] [Related]
6. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors. Phan AT; Kunz PL; Reidy-Lagunes DL Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956 [TBL] [Abstract][Full Text] [Related]
7. Gastroenteropancreatic neuroendocrine tumors: Role of surgery. Sauvanet A Ann Endocrinol (Paris); 2019 Jun; 80(3):175-181. PubMed ID: 31079831 [TBL] [Abstract][Full Text] [Related]
8. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604 [TBL] [Abstract][Full Text] [Related]
9. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis. Zheng M; Li Y; Li T; Zhang L; Zhou L Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428 [TBL] [Abstract][Full Text] [Related]
10. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations. Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286 [TBL] [Abstract][Full Text] [Related]
12. Surgery on neuroendocrine tumours. Akerström G; Hellman P Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):87-109. PubMed ID: 17382267 [TBL] [Abstract][Full Text] [Related]
13. Upfront surgery of small intestinal neuroendocrine tumors. Time to reconsider? Daskalakis K; Tsolakis AV World J Gastroenterol; 2018 Aug; 24(29):3201-3203. PubMed ID: 30090001 [TBL] [Abstract][Full Text] [Related]
14. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms. Chakedis J; Beal EW; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha FG; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Marincola-Smith P; Cho C; Beems M; Pawlik TM; Maithel SK; Schmidt CR; Dillhoff M J Gastrointest Surg; 2019 Jan; 23(1):122-134. PubMed ID: 30334178 [TBL] [Abstract][Full Text] [Related]
15. Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract. Goretzki PE; Mogl MT; Akca A; Pratschke J Rev Endocr Metab Disord; 2018 Jun; 19(2):169-178. PubMed ID: 30280290 [TBL] [Abstract][Full Text] [Related]
16. Update in the Therapy of Advanced Neuroendocrine Tumors. Uri I; Avniel-Polak S; Gross DJ; Grozinsky-Glasberg S Curr Treat Options Oncol; 2017 Nov; 18(12):72. PubMed ID: 29143892 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases. Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571 [TBL] [Abstract][Full Text] [Related]
18. Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome. Panzuto F; Merola E; Pavel ME; Rinke A; Kump P; Partelli S; Rinzivillo M; Rodriguez-Laval V; Pape UF; Lipp R; Gress T; Wiedenmann B; Falconi M; Delle Fave G Oncologist; 2017 Apr; 22(4):409-415. PubMed ID: 28232598 [TBL] [Abstract][Full Text] [Related]